We have a long history of making an impact in cardio-metabolic disorders, such as type 2 diabetes and cardiovascular disease.
More than 60 years ago, we introduced our first cardiovascular therapy – and our scientific efforts to deeply understand cardio-metabolic disorders have continued
Cardio-metabolic disorders include cardiovascular diseases and metabolic diseases, such as type 2 diabetes. These represent some of the most serious health challenges of the 21st century.
Advancements in cardio-metabolic research can make an impactful difference for patients, and there is still much more work to be done. We strive for scientific excellence and innovation in all stages of research, from discovery through approval and afterwards.
The impact of cardio-metabolic disorders
We continue to build on our history of innovative therapies in cardiovascular disease to help increase our understanding and help patients around the world.
We work with experts throughout the cardiovascular community to advance research that can help improve the lives of patients with cardiovascular risk.
We are proud to be part of the research team that is committed to bringing forward scientific excellence and innovation to help people with type 2 diabetes.
There are so many aspects of cardio-metabolic disorders
Sharing our stories is a privilege. Let's keep inspiring each other until these health challenges are in the past.
Heart failure: A physician’s perspective
Driven to make a difference By Dr. Joerg Koglin, vice president, therapeutic area head, global clinical development, cardiovascular, Merck Research Laboratories
Bridging the gap: reducing disparities in diabetes care
This initiative brings together the health care sector and other sectors to support innovative approaches to diabetes treatment and management.
Our commitment to patients is unwavering
As long as there are still patients in hospitals, doctors desperate to add years to the lives of their patients, and a world where treatments aren’t accessible to all, we will be here, fighting with all we have to deliver more, sooner.